# A Study of Dayingpian Treating Bipolar Disorder

> **NCT05247593** · — · UNKNOWN · sponsor: **Shanghai Mental Health Center** · enrollment: 308 (estimated)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Dayingpian
- **DRUG:** conventional mood stabilizers

## Key facts

- **NCT ID:** NCT05247593
- **Lead sponsor:** Shanghai Mental Health Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-08-01
- **Primary completion:** 2024-06
- **Final completion:** 2024-09
- **Target enrollment:** 308 (ESTIMATED)
- **Last updated:** 2022-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05247593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05247593, "A Study of Dayingpian Treating Bipolar Disorder". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT05247593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*